Related Experiment Video
Updated: Nov 27, 2025
08:09
Validation of Nanobody and Antibody Based In Vivo Tumor Xenograft NIRF-imaging Experiments in Mice Using Ex Vivo Flow Cytometry and Microscopy
Published on: April 6, 2015
11.9K
Nanobodies in cancer
Elisha R Verhaar1, Andrew W Woodham2, Hidde L Ploegh2
1Program in Cellular and Molecular Medicine, Boston Children's Hospital, Boston, United States.
Seminars in Immunology
|December 4, 2020
Summary
Nanobodies, derived from camelids, are valuable antibody fragments for cancer diagnosis and therapy. Their small size, stability, and targeting capabilities make them promising tools in tumor biology research and applications.
Area of Science:
- Biotechnology
- Immunology
- Oncology
Background:
- Antibodies are crucial for cancer treatment and diagnosis.
- Nanobodies, derived from camelid heavy chain-only antibodies, are emerging as versatile tools.
Purpose of the Study:
- To review the applications of nanobodies in tumor biology.
- To highlight the potential of nanobodies in cancer diagnostics and therapeutics.
Main Methods:
- Review of existing literature on nanobody applications in cancer research.
- Analysis of nanobody characteristics relevant to tumor biology.
Main Results:
- Nanobodies show promise as diagnostic tools and building blocks for cancer therapies.
- Their small size, stability, and high specificity contribute to their effectiveness.
Conclusions:
- Nanobodies offer significant advantages for applications in tumor biology.
- Further development of nanobodies could lead to novel cancer treatments and diagnostics.
